NEWAMSTERDAM PHARMA CO NV(NAMS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NAMS NEWAMSTERDAM PHARMA CO NV

未开盘 12-20 16:00:00 EST

25.50

+0.04

+0.16%

盘后25.50

+0.000.00%

18:27 EST

最高26.25	最低24.55	成交量102.63万
今开24.86	昨收25.46	日振幅6.68%
总市值26.65亿	流通市值12.03亿	总股本1.05亿
成交额2,620万	换手率2.17%	流通股本4,719万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NAMS","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV","latestPrice":25.5,"timestamp":1734728400000,"preClose":25.46,"halted":0,"volume":1026267,"hourTrading":{"tag":"盘后","latestPrice":25.5,"preClose":25.5,"latestTime":"18:27 EST","volume":25826,"amount":658563.49,"timestamp":1734737253085},"delay":0,"floatShares":47194500,"shares":104503219,"eps":-2.207272,"marketStatus":"未开盘","marketStatusCode":0,"change":0.04,"latestTime":"12-20 16:00:00 EST","open":24.86,"high":26.25,"low":24.55,"amount":26201922.446964,"amplitude":0.066771,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.207272,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"adjPreClose":25.46,"preHourTrading":{"tag":"盘前","latestPrice":26.39,"preClose":25.46,"latestTime":"08:59 EST","volume":134,"amount":3253.00008,"timestamp":1734703158013},"postHourTrading":{"tag":"盘后","latestPrice":25.5,"preClose":25.5,"latestTime":"18:27 EST","volume":25826,"amount":658563.49,"timestamp":1734737253085},"volumeRatio":0.9341706641791974,"impliedVol":0.4657,"impliedVolPercentile":0.1227},"requestUrl":"/m/hq/s/NAMS","defaultTab":"news","newsList":[{"id":"2492153744","title":"Newamsterdam Pharma Company N.V.盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492153744?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:05","pubTimestamp":1734552311,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时05分，Newamsterdam Pharma Company N.V.股票出现异动，股价快速跳水5.07%。截至发稿，该股报25.26美元/股，成交量63.2441万股，换手率0.59%，振幅5.45%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为2.02%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040511a1f94c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040511a1f94c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2492993393","title":"Newamsterdam Pharma Company N.V.盘中异动 急速上涨5.18%报25.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492993393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492993393?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:22","pubTimestamp":1734456158,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时22分，Newamsterdam Pharma Company N.V.股票出现异动，股价急速拉升5.18%。截至发稿，该股报25.99美元/股，成交量64.2548万股，换手率0.60%，振幅6.03%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为0.85%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801223895ea34e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121801223895ea34e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2490864789","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘股价大跌5.00%报24.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490864789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490864789?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:07","pubTimestamp":1733933268,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日00时07分，Newamsterdam Pharma Company N.V.股票出现波动，股价大幅跳水5.00%。截至发稿，该股报24.88美元/股，成交量48.2044万股，换手率0.52%，振幅9.20%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为0.66%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121200074995e8fc45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121200074995e8fc45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NAMS","BK4139","CADL"],"gpt_icon":0},{"id":"2490401916","title":"Newamsterdam Pharma Company N.V.股价拉升28.97% 市值涨6.39亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490401916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490401916?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:32","pubTimestamp":1733841129,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时32分，Newamsterdam Pharma Company N.V.股票出现异动，股价快速上涨28.97%。截至发稿，该股报23.89美元/股，成交量172.632万股，换手率1.87%，振幅14.96%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为0.01%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223209a1e39855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223209a1e39855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2488118108","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘股价大跌5.28%报18.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488118108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488118108?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:27","pubTimestamp":1733326030,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时27分，Newamsterdam Pharma Company N.V.股票出现异动，股价大幅下跌5.28%。截至发稿，该股报18.93美元/股，成交量18.7334万股，换手率0.20%，振幅4.86%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为0.16%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423271098e55fab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120423271098e55fab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2487556550","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487556550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487556550?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:11","pubTimestamp":1732893098,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时11分，Newamsterdam Pharma Company N.V.股票出现波动，股价快速下挫5.53%。截至发稿，该股报19.65美元/股，成交量7.3635万股，换手率0.08%，振幅5.24%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为0.20%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923113898e46848&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112923113898e46848&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2486880295","title":"Newamsterdam Pharma Company N.V.盘中异动 下午盘急速下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486880295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486880295?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:55","pubTimestamp":1732647315,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日02时55分，Newamsterdam Pharma Company N.V.股票出现波动，股价快速下跌5.34%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为0.24%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127025515abe12e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127025515abe12e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2486038559","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038559?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:34","pubTimestamp":1732545257,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时34分，Newamsterdam Pharma Company N.V.股票出现异动，股价急速拉升5.00%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为1.09%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223417971a85c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223417971a85c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2485497246","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘股价大涨5.27%报21.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497246?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:33","pubTimestamp":1732199633,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时33分，Newamsterdam Pharma Company N.V.股票出现波动，股价大幅上涨5.27%。截至发稿，该股报21.07美元/股，成交量3.3612万股，换手率0.04%，振幅4.66%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为0.02%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223353971a7e04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223353971a7e04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2484110873","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘快速跳水10.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110873","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110873?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:32","pubTimestamp":1732113122,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时32分，Newamsterdam Pharma Company N.V.股票出现异动，股价大幅下跌10.39%。截至发稿，该股报21.22美元/股，成交量35.4324万股，换手率0.38%，振幅6.08%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为0.37%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022320295be4cca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022320295be4cca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2484192430","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484192430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484192430?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:05","pubTimestamp":1732032300,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时05分，Newamsterdam Pharma Company N.V.股票出现异动，股价快速下跌5.03%。截至发稿，该股报23.42美元/股，成交量11.686万股，换手率0.13%，振幅4.14%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为0.73%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000050098e438c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000050098e438c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2481215958","title":"Newamsterdam Pharma Company N.V.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481215958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481215958?lang=zh_cn&edition=full","pubTime":"2024-11-08 04:39","pubTimestamp":1731011982,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日04时39分，Newamsterdam Pharma Company N.V.股票出现波动，股价快速拉升5.00%。截至发稿，该股报22.87美元/股，成交量19.738万股，换手率0.21%，振幅4.61%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为1.23%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108043942971a52ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108043942971a52ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2481632384","title":"Newamsterdam Pharma Company N.V.盘中异动 快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481632384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481632384?lang=zh_cn&edition=full","pubTime":"2024-11-06 03:04","pubTimestamp":1730833453,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日03时04分，Newamsterdam Pharma Company N.V.股票出现异动，股价大幅拉升5.10%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为1.74%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106030413971a47ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106030413971a47ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2479033756","title":"Newamsterdam Pharma Company N.V.盘中异动 大幅下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033756?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:55","pubTimestamp":1730382915,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时55分，Newamsterdam Pharma Company N.V.股票出现波动，股价快速下挫5.39%。截至发稿，该股报17.03美元/股，成交量1.3183万股，换手率0.01%，振幅5.14%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为2.26%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215515971a38d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215515971a38d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2475311836","title":"Newamsterdam Pharma Company N.V.盘中异动 下午盘大幅拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475311836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475311836?lang=zh_cn&edition=full","pubTime":"2024-10-15 02:31","pubTimestamp":1728930680,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日02时31分，Newamsterdam Pharma Company N.V.股票出现波动，股价快速上涨5.44%。截至发稿，该股报19.18美元/股，成交量20.0319万股，换手率0.22%，振幅5.66%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为0.59%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015023121a1e09629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015023121a1e09629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2473480406","title":"Newamsterdam Pharma Company N.V.盘中异动 下午盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473480406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473480406?lang=zh_cn&edition=full","pubTime":"2024-10-08 03:19","pubTimestamp":1728328793,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日03时19分，Newamsterdam Pharma Company N.V.股票出现波动，股价急速跳水5.16%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为0.24%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008031953ab682388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008031953ab682388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2468507534","title":"Newamsterdam Pharma Company N.V.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468507534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468507534?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:21","pubTimestamp":1726762883,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日00时21分，Newamsterdam Pharma Company N.V.股票出现异动，股价快速拉升5.11%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为1.24%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200021239719be46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200021239719be46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2458297533","title":"Newamsterdam Pharma Company N.V.盘中异动 临近收盘股价大涨5.30%报16.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458297533","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458297533?lang=zh_cn&edition=full","pubTime":"2024-08-09 03:39","pubTimestamp":1723145972,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日03时39分，Newamsterdam Pharma Company N.V.股票出现异动，股价大幅拉升5.30%。截至发稿，该股报16.49美元/股，成交量10.1944万股，换手率0.11%，振幅5.14%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为3.32%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。其产品 obicetrapib 是下一代口服低剂量 CETP 抑制剂，为了克服当前 LDL-C 降低治疗的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809033932aefdf56a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809033932aefdf56a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2457353771","title":"Newamsterdam Pharma Company N.V.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457353771","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457353771?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864775,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Newamsterdam Pharma Company N.V.股票出现波动，股价急速跳水5.30%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体跌幅为1.36%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213255941fe310&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213255941fe310&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2456161917","title":"Newamsterdam Pharma Company N.V.盘中异动 急速拉升6.12%报17.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456161917","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456161917?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:54","pubTimestamp":1722452085,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日02时54分，Newamsterdam Pharma Company N.V.股票出现异动，股价快速拉升6.12%。截至发稿，该股报17.17美元/股，成交量17.2881万股，换手率0.19%，振幅6.43%。Newamsterdam Pharma Company N.V.股票所在的生物技术行业中，整体涨幅为0.84%。Newamsterdam Pharma Company N.V.公司简介：NewAmsterdam Pharma Co NV 是一家处于后研发阶段的生物制药公司，其使命是改善代谢性疾病患者的护理，这些疾病目前批准的疗法尚未充分或耐受性良好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801025445941fca9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801025445941fca9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAMS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.newamsterdampharma.com","stockEarnings":[{"period":"1week","weight":0.0328},{"period":"1month","weight":0.2744},{"period":"3month","weight":0.6018},{"period":"6month","weight":0.4151},{"period":"1year","weight":1.2788},{"period":"ytd","weight":1.2829}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NewAmsterdam Pharma Company N.V.于2019年10月17日以NewAmsterdam Pharma B.V.的名义根据荷兰法律成立为一家私人有限责任公司。NewAmsterdam Pharma于2021年10月更名为NewAmsterdam Pharma Holding B.V.。他们是一家临床阶段的生物制药公司，为心血管疾病（CVD）高危患者开发口服非他汀类药物，这些患者的低密度脂蛋白胆固醇（LDL-C或LDL）残留升高，而现有疗法对这些患者不够有效或耐受良好。作为他汀类药物的辅助药物，一种有效的、具有成本效益的和方便的低密度脂蛋白降低疗法存在着巨大的未满足需求。他汀类药物是目前高胆固醇高危CVD患者的标准护理。他们的主要候选产品obicetrapib是一种下一代口服低剂量胆固醇酯转移蛋白（CETP）抑制剂，目前正在进行四项3期和2b期临床试验，作为单一疗法和依折麦布联合疗法，用于降低LDL-C和预防主要心血管不良事件（“MACE”）。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.354926},{"month":2,"riseRate":0.333333,"avgChangeRate":0.033892},{"month":3,"riseRate":0.75,"avgChangeRate":0.004664},{"month":4,"riseRate":0.5,"avgChangeRate":-0.00065},{"month":5,"riseRate":0,"avgChangeRate":-0.047858},{"month":6,"riseRate":0.75,"avgChangeRate":-0.027601},{"month":7,"riseRate":0.25,"avgChangeRate":-0.036015},{"month":8,"riseRate":0.25,"avgChangeRate":-0.035988},{"month":9,"riseRate":0.75,"avgChangeRate":-0.018319},{"month":10,"riseRate":0.5,"avgChangeRate":0.000568},{"month":11,"riseRate":0.5,"avgChangeRate":0.013756},{"month":12,"riseRate":0.75,"avgChangeRate":0.193184}],"exchange":"NASDAQ","name":"NEWAMSTERDAM PHARMA CO NV","nameEN":"NEWAMSTERDAM PHARMA CO NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NEWAMSTERDAM PHARMA CO NV(NAMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NEWAMSTERDAM PHARMA CO NV(NAMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NEWAMSTERDAM PHARMA CO NV,NAMS,NEWAMSTERDAM PHARMA CO NV股票,NEWAMSTERDAM PHARMA CO NV股票老虎,NEWAMSTERDAM PHARMA CO NV股票老虎国际,NEWAMSTERDAM PHARMA CO NV行情,NEWAMSTERDAM PHARMA CO NV股票行情,NEWAMSTERDAM PHARMA CO NV股价,NEWAMSTERDAM PHARMA CO NV股市,NEWAMSTERDAM PHARMA CO NV股票价格,NEWAMSTERDAM PHARMA CO NV股票交易,NEWAMSTERDAM PHARMA CO NV股票购买,NEWAMSTERDAM PHARMA CO NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NEWAMSTERDAM PHARMA CO NV(NAMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NEWAMSTERDAM PHARMA CO NV(NAMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}